Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada.

Harris GE, Dupuis L, Mugford GJ, Johnston L, Haase D, Page G, Haldane H, Harris N, Midodzi WK, Dow G.

Can J Infect Dis Med Microbiol. 2014 Spring;25(1):e1-7.

PMID:
24634690
[PubMed]
2.

Medicinal and recreational marijuana use by patients infected with HIV.

Furler MD, Einarson TR, Millson M, Walmsley S, Bendayan R.

AIDS Patient Care STDS. 2004 Apr;18(4):215-28.

PMID:
15142352
[PubMed - indexed for MEDLINE]
3.

[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.

Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19. French.

PMID:
19540408
[PubMed - indexed for MEDLINE]
4.

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.

Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E.

Psychopharmacology (Berl). 2004 May;173(3-4):398-404. Epub 2004 Jan 14.

PMID:
14722704
[PubMed - indexed for MEDLINE]
5.

The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.

Lutge EE, Gray A, Siegfried N.

Cochrane Database Syst Rev. 2013 Apr 30;4:CD005175. doi: 10.1002/14651858.CD005175.pub3. Review.

PMID:
23633327
[PubMed - indexed for MEDLINE]
6.

[Cannabis cessation interventions offered to young French users: predictors of follow-up].

Abdoul H, Le Faou AL, Bouchez J, Touzeau D, Lagrue G.

Encephale. 2012 Apr;38(2):141-8. doi: 10.1016/j.encep.2011.04.007. Epub 2011 Aug 31. French.

PMID:
22516272
[PubMed - indexed for MEDLINE]
7.

Cannabis use for chronic non-cancer pain: results of a prospective survey.

Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ.

Pain. 2003 Mar;102(1-2):211-6.

PMID:
12620613
[PubMed - indexed for MEDLINE]
8.

[Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].

Chabrol H, Mabila JD, Chauchard E, Mantoulan R, Rousseau A.

Encephale. 2008 Jan;34(1):8-16. doi: 10.1016/j.encep.2007.01.002. Epub 2007 Sep 4. French.

PMID:
18514145
[PubMed - indexed for MEDLINE]
9.

The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.

Scott LA, Roxburgh A, Bruno R, Matthews A, Burns L.

Addict Behav. 2012 Sep;37(9):1058-62. doi: 10.1016/j.addbeh.2012.04.012. Epub 2012 Apr 28.

PMID:
22607716
[PubMed - indexed for MEDLINE]
10.

Long-term cannabis use: characteristics of users in an Australian rural area.

Reilly D, Didcott P, Swift W, Hall W.

Addiction. 1998 Jun;93(6):837-46.

PMID:
9744119
[PubMed - indexed for MEDLINE]
11.

Adverse effects of cannabis.

[No authors listed]

Prescrire Int. 2011 Jan;20(112):18-23. Review.

PMID:
21462790
[PubMed - indexed for MEDLINE]
12.

Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting.

Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM.

J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):38-45.

PMID:
14707790
[PubMed - indexed for MEDLINE]
13.

Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.

Thornton LK, Baker AL, Johnson MP, Lewin T.

Addict Behav. 2013 Jun;38(6):2246-51. doi: 10.1016/j.addbeh.2013.02.003. Epub 2013 Feb 18.

PMID:
23507458
[PubMed - indexed for MEDLINE]
14.

Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.

Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, Holtzman S.

Int J Drug Policy. 2013 Nov;24(6):511-6. doi: 10.1016/j.drugpo.2013.08.010. Epub 2013 Sep 9.

PMID:
24095000
[PubMed - indexed for MEDLINE]
15.

Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.

Milani RM, Parrott AC, Schifano F, Turner JJ.

Hum Psychopharmacol. 2005 Jun;20(4):249-61.

PMID:
15816011
[PubMed - indexed for MEDLINE]
16.

Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?

Martínez-Rodríguez JE, Munteis E, Carreño M, Blanco Y, Roquer J, Abanades S, Graus F, Saiz A.

J Neurol Sci. 2008 Oct 15;273(1-2):103-7. doi: 10.1016/j.jns.2008.06.037. Epub 2008 Aug 8.

PMID:
18691726
[PubMed - indexed for MEDLINE]
17.

Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.

George J, Kinner SA, Bruno R, Degenhardt L, Dunn M.

Drug Alcohol Rev. 2010 May;29(3):243-9. doi: 10.1111/j.1465-3362.2009.00159.x.

PMID:
20565515
[PubMed - indexed for MEDLINE]
18.

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.

MacInnes N, Handley SL, Harding GF.

J Psychopharmacol. 2001 Sep;15(3):181-6.

PMID:
11565625
[PubMed - indexed for MEDLINE]
19.

Barriers to access to medical cannabis for Canadians living with HIV/AIDS.

Belle-Isle L, Hathaway A.

AIDS Care. 2007 Apr;19(4):500-6.

PMID:
17453590
[PubMed - indexed for MEDLINE]
20.

Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.

de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, Poudevida S, Farré M, Verdejo-García A, de la Torre R.

Psychopharmacology (Berl). 2008 Oct;200(3):425-37. doi: 10.1007/s00213-008-1217-5. Epub 2008 Jun 26.

PMID:
18581098
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk